Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕HDFC MNC Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC MNC Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹591.2429₹14.1460
NAV date20 Nov 202620 Nov 2026
History20.6 years3.7 years
Expense ratio1.8%2.9%
Stars★★★★★★★★★★
Growth Score78.3020.10

Returns

Nippon India Pharma FundHDFC MNC Fund
1 month+11.32%+7.48%
3 months+3.52%−1.01%
6 months+8.09%+7.48%
YTD+16.05%+4.41%
1 year+14.27%+5.45%
3 years (CAGR)+16.91%+6.63%
5 years (CAGR)+14.37%—
10 years (CAGR)+15.58%—
Since launch+17.64%+9.78%

Risk

Nippon India Pharma FundHDFC MNC Fund
Volatility14.1%17.0%
Downside volatility9.1%12.7%
Sharpe0.740.01
Sortino1.150.01
Calmar1.140.27
Return / risk1.200.39
Deepest fall−47.36%−24.89%
Days to recover301—
Below its high0.00%−8.17%

Against benchmark

Nippon India Pharma FundHDFC MNC Fund
Alpha−2.95%−4.91%
Beta0.890.87
R²89.5%89.2%
Up capture83.2%79.4%
Down capture91.8%96.9%
Tracking error4.9%6.1%
Information ratio−0.93−0.95
Treynor0.110.00

Consistency

Nippon India Pharma FundHDFC MNC Fund
Best 1-year+175.79%+34.44%
Middle 1-year+13.84%+2.77%
Worst 1-year−36.67%−12.25%
1-year periods with a loss23.4%38.8%
Middle 3-year+20.93%+6.78%
Positive months63.9%63.9%
Best day+3.40%+3.17%
Worst day−3.21%−3.83%
Worst 5% day−1.38%−1.51%
Positive days53.7%53.9%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC MNC Fund
5-year XIRR+17.18%—
5-year value₹9,29,284—
3-year XIRR+13.26%+4.31%
1-year XIRR+21.05%+9.60%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • HDFC MNC Fund: no monthly portfolio filing is loaded, so it is left out here. HDFC Mutual Fund's website blocks automatic downloads, so its monthly file has to be added by hand and none is loaded yet.

Search Growth